Injectable Weight Loss Drugs: How Illegal Online Drug Sellers Are Taking Advantage of Patients
(2018) about the capacity of DTG to eject Zn 2+ ions from zinc-dependent metalloproteins, represents a significant finding that will allow investigation of the biological role of gliotoxin in the context of regulating zinc homeostasis which, simultaneously, will broaden the potential practical applications of this fascinating compound
Eli Lilly and Companys next-generation injectable (retatrutide) is showing even greater weight loss and blood sugar reductions than todays GLP-1s, with ~1517% weight loss in diabetes patients and prior data approaching ~25%+ in obesitypotentially the most effective therapy weve seen to date
NEDA cautions that for people with active eating disorders or a history of disordered eating, these drugs can be harmful when not used for their intended purpose, when inadequately monitored or monitored by clinicians without eating disorder expertise, or when used for weight loss motivated by weight stigma. That doesnt mean GLP-1s are automatically off the table, but it does mean that this decision warrants extra care, specialist input, and close monitoring throughout
